{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:07:34Z","timestamp":1788919654385,"version":"build-2803163510"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7244374"],"award-info":[{"award-number":["7244374"]}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["GZC20230307"],"award-info":[{"award-number":["GZC20230307"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Key Laboratory Special Fund","award":["2060204"],"award-info":[{"award-number":["2060204"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2023-I2M-2-001"],"award-info":[{"award-number":["2023-I2M-2-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-03028-2","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:24:57Z","timestamp":1782365097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amino-acids-mTORC1-driven DDA1 phosphorylation promotes DNA repair and glioblastoma progression"],"prefix":"10.1186","volume":"24","author":[{"given":"Xing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doudou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwen","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9592-9554","authenticated-orcid":false,"given":"Xiaozhong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"1","key":"3028_CR1","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1038\/s41467-024-50584-7","volume":"15","author":"DA Llerena Schiffmacher","year":"2024","unstructured":"Llerena Schiffmacher DA, Lee SH, Kliza KW, et al. The small CRL4(CSA) ubiquitin ligase component DDA1 regulates transcription-coupled repair dynamics. Nat Commun. 2024;15(1):6374.","journal-title":"Nat Commun"},{"key":"3028_CR2","unstructured":"Schiffmacher DL, Lee SH, Kliza KW, et al. DDA1, a novel factor in transcription-coupled repair, modulates CRL4(CSA) dynamics at DNA damage-stalled RNA polymerase II. Res Sq. 2023:rs.3.rs\u20133385435."},{"issue":"9","key":"3028_CR3","doi-asserted-by":"publisher","first-page":"eadq4187","DOI":"10.1126\/sciadv.adq4187","volume":"11","author":"AE Burgess","year":"2025","unstructured":"Burgess AE, Loughran TA, Turk LS, et al. DET1 dynamics underlie cooperative ubiquitination by CRL4(DET1-COP1) complexes. Sci Adv. 2025;11(9):eadq4187.","journal-title":"Sci Adv"},{"issue":"13","key":"3028_CR4","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1128\/MCB.02432-06","volume":"27","author":"E Pick","year":"2007","unstructured":"Pick E, Lau OS, Tsuge T, et al. Mammalian DET1 regulates Cul4A activity and forms stable complexes with E2 ubiquitin-conjugating enzymes. Mol Cell Biol. 2007;27(13):4708\u201319.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"3028_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41556-024-01394-y","volume":"26","author":"M van Sluis","year":"2024","unstructured":"van Sluis M, Yu Q, van der Woude M, et al. Transcription-coupled DNA-protein crosslink repair by CSB and CRL4(CSA)-mediated degradation. Nat Cell Biol. 2024;26(5):770\u201383.","journal-title":"Nat Cell Biol"},{"issue":"16","key":"3028_CR6","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1093\/nar\/gkae618","volume":"52","author":"C Gonzalo-Hansen","year":"2024","unstructured":"Gonzalo-Hansen C, Steurer B, Janssens RC, et al. Differential processing of RNA polymerase II at DNA damage correlates with transcription-coupled repair syndrome severity. Nucleic Acids Res. 2024;52(16):9596\u2013612.","journal-title":"Nucleic Acids Res"},{"issue":"Pt 7","key":"3028_CR7","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1242\/jcs.043539","volume":"122","author":"MH Olma","year":"2009","unstructured":"Olma MH, Roy M, Le Bihan T, et al. An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases. J Cell Sci. 2009;122(Pt 7):1035\u201344.","journal-title":"J Cell Sci"},{"issue":"2","key":"3028_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1142\/S0192415X23500234","volume":"51","author":"J Zhang","year":"2023","unstructured":"Zhang J, Li Y, Wang JG, Feng JY, Huang GD, Luo CG. Dihydroartemisinin Affects STAT3\/DDA1 Signaling Pathway and Reverses Breast Cancer Resistance to Cisplatin. Am J Chin Med. 2023;51(2):445\u201359.","journal-title":"Am J Chin Med"},{"issue":"8","key":"3028_CR9","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/jcmm.13084","volume":"21","author":"L Cheng","year":"2017","unstructured":"Cheng L, Yang Q, Li C, et al. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle. J Cell Mol Med. 2017;21(8):1532\u201344.","journal-title":"J Cell Mol Med"},{"issue":"15","key":"3028_CR10","doi-asserted-by":"publisher","first-page":"19794","DOI":"10.18632\/oncotarget.7847","volume":"7","author":"S Zhao","year":"2016","unstructured":"Zhao S, Tang H, Yan D, et al. DDA1 promotes stage IIB-IIC colon cancer progression by activating NFkappaB\/CSN2\/GSK-3beta signaling. Oncotarget. 2016;7(15):19794\u2013812.","journal-title":"Oncotarget"},{"issue":"7","key":"3028_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrm3822","volume":"15","author":"JA Marteijn","year":"2014","unstructured":"Marteijn JA, Lans H, Vermeulen W, Hoeijmakers JH. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol. 2014;15(7):465\u201381.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"24","key":"3028_CR12","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1016\/j.molcel.2024.10.030","volume":"84","author":"AR Ramadhin","year":"2024","unstructured":"Ramadhin AR, Lee SH, Zhou D, et al. STK19 drives transcription-coupled repair by stimulating repair complex stability, RNA Pol II ubiquitylation, and TFIIH recruitment. Mol Cell. 2024;84(24):4740\u2013e47574712.","journal-title":"Mol Cell"},{"key":"3028_CR13","doi-asserted-by":"publisher","first-page":"103566","DOI":"10.1016\/j.dnarep.2023.103566","volume":"130","author":"DA Llerena Schiffmacher","year":"2023","unstructured":"Llerena Schiffmacher DA, Kliza KW, Theil AF, et al. Live cell transcription-coupled nucleotide excision repair dynamics revisited. DNA Repair (Amst). 2023;130:103566.","journal-title":"DNA Repair (Amst)"},{"key":"3028_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mrrev.2016.05.005","volume":"769","author":"H Erasimus","year":"2016","unstructured":"Erasimus H, Gobin M, Niclou S, Van Dyck E. DNA repair mechanisms and their clinical impact in glioblastoma. Mutat Res Rev Mutat Res. 2016;769:19\u201335.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"2","key":"3028_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017;169(2):361\u201371.","journal-title":"Cell"},{"issue":"2","key":"3028_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393.","journal-title":"Cell"},{"issue":"8","key":"3028_CR17","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.cell.2021.03.060","volume":"184","author":"MK Holz","year":"2021","unstructured":"Holz MK, Ballif BA, Gygi SP, Blenis J, mTOR. S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell. 2021;184(8):2255.","journal-title":"Cell"},{"issue":"1","key":"3028_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20110892","volume":"441","author":"B Magnuson","year":"2012","unstructured":"Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012;441(1):1\u201321.","journal-title":"Biochem J"},{"issue":"11","key":"3028_CR19","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.molcel.2021.03.031","volume":"81","author":"R Bohm","year":"2021","unstructured":"Bohm R, Imseng S, Jakob RP, Hall MN, Maier T, Hiller S. The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1. Mol Cell. 2021;81(11):2403\u2013e24162405.","journal-title":"Mol Cell"},{"issue":"5882","key":"3028_CR20","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak Y, Peterson TR, Shaul YD, et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. 2008;320(5882):1496\u2013501.","journal-title":"Science"},{"issue":"35","key":"3028_CR21","doi-asserted-by":"publisher","first-page":"e2322755121","DOI":"10.1073\/pnas.2322755121","volume":"121","author":"ML Valenstein","year":"2024","unstructured":"Valenstein ML, Lalgudi PV, Gu X, et al. Rag-Ragulator is the central organizer of the physical architecture of the mTORC1 nutrient-sensing pathway. Proc Natl Acad Sci U S A. 2024;121(35):e2322755121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3028_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 2010;141(2):290\u2013303.","journal-title":"Cell"},{"issue":"6136","key":"3028_CR23","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.1232044","volume":"340","author":"L Bar-Peled","year":"2013","unstructured":"Bar-Peled L, Chantranupong L, Cherniack AD, et al. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science. 2013;340(6136):1100\u20136.","journal-title":"Science"},{"issue":"1","key":"3028_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cell.2014.08.038","volume":"159","author":"M Peng","year":"2014","unstructured":"Peng M, Yin N, Li MO. Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling. Cell. 2014;159(1):122\u201333.","journal-title":"Cell"},{"issue":"6268","key":"3028_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.aab2674","volume":"351","author":"RL Wolfson","year":"2016","unstructured":"Wolfson RL, Chantranupong L, Saxton RA, et al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science. 2016;351(6268):43\u20138.","journal-title":"Science"},{"issue":"6364","key":"3028_CR26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aao3265","volume":"358","author":"X Gu","year":"2017","unstructured":"Gu X, Orozco JM, Saxton RA, et al. SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science. 2017;358(6364):813\u20138.","journal-title":"Science"},{"issue":"1","key":"3028_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cell.2016.02.035","volume":"165","author":"L Chantranupong","year":"2016","unstructured":"Chantranupong L, Scaria SM, Saxton RA, et al. The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway. Cell. 2016;165(1):153\u201364.","journal-title":"Cell"},{"issue":"12","key":"3028_CR28","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41580-023-00641-8","volume":"24","author":"C Goul","year":"2023","unstructured":"Goul C, Peruzzo R, Zoncu R. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nat Rev Mol Cell Biol. 2023;24(12):857\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"3028_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.molmed.2012.05.007","volume":"18","author":"A Efeyan","year":"2012","unstructured":"Efeyan A, Zoncu R, Sabatini DM. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med. 2012;18(9):524\u201333.","journal-title":"Trends Mol Med"},{"issue":"724","key":"3028_CR30","doi-asserted-by":"publisher","first-page":"eadd0499","DOI":"10.1126\/scitranslmed.add0499","volume":"15","author":"MR Khan","year":"2023","unstructured":"Khan MR, Yin X, Kang SU, et al. Enhanced mTORC1 signaling and protein synthesis in pathologic alpha-synuclein cellular and animal models of Parkinson\u2019s disease. Sci Transl Med. 2023;15(724):eadd0499.","journal-title":"Sci Transl Med"},{"issue":"16","key":"3028_CR31","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/onc.2016.363","volume":"36","author":"LC Kim","year":"2017","unstructured":"Kim LC, Cook RS, Chen J. mTORC1 and mTORC2 in cancer and the tumor microenvironment. Oncogene. 2017;36(16):2191\u2013201.","journal-title":"Oncogene"},{"issue":"5","key":"3028_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/01616412.2022.2149516","volume":"45","author":"Y Gao","year":"2023","unstructured":"Gao Y, Jing N, Teng X, Wang Y. Serine hydroxymethyltransferase 1 promotes low-grade glioma progression by activating mTORC1 signaling. Neurol Res. 2023;45(5):415\u201322.","journal-title":"Neurol Res"},{"issue":"1","key":"3028_CR33","doi-asserted-by":"publisher","first-page":"20956","DOI":"10.1038\/s41598-023-47892-1","volume":"13","author":"K Tsutsumi","year":"2023","unstructured":"Tsutsumi K, Nohara A, Tanaka T, Murano M, Miyagaki Y, Ohta Y. FilGAP regulates tumor growth in Glioma through the regulation of mTORC1 and mTORC2. Sci Rep. 2023;13(1):20956.","journal-title":"Sci Rep"},{"key":"3028_CR34","doi-asserted-by":"publisher","first-page":"100854","DOI":"10.1016\/j.jbior.2021.100854","volume":"83","author":"M Jhanwar-Uniyal","year":"2022","unstructured":"Jhanwar-Uniyal M, Dominguez JF, Mohan AL, Tobias ME, Gandhi CD. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma. Adv Biol Regul. 2022;83:100854.","journal-title":"Adv Biol Regul"},{"issue":"12","key":"3028_CR35","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1021\/acs.jproteome.2c00240","volume":"21","author":"N Kalpongnukul","year":"2022","unstructured":"Kalpongnukul N, Bootsri R, Wongkongkathep P, et al. Phosphoproteomic Analysis Defines BABAM1 as mTORC2 Downstream Effector Promoting DNA Damage Response in Glioblastoma Cells. J Proteome Res. 2022;21(12):2893\u2013904.","journal-title":"J Proteome Res"},{"issue":"7","key":"3028_CR36","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/15548627.2015.1009795","volume":"11","author":"EC Filippi-Chiela","year":"2015","unstructured":"Filippi-Chiela EC, Bueno e Silva MM, Thome MP, Lenz G. Single-cell analysis challenges the connection between autophagy and senescence induced by DNA damage. Autophagy. 2015;11(7):1099\u2013113.","journal-title":"Autophagy"},{"issue":"5","key":"3028_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41416-018-0368-3","volume":"120","author":"M Foltyn","year":"2019","unstructured":"Foltyn M, Luger AL, Lorenz NI, et al. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. Br J Cancer. 2019;120(5):481\u20137.","journal-title":"Br J Cancer"},{"key":"3028_CR38","doi-asserted-by":"crossref","unstructured":"Boylan J, Byers E, Kelly DF. The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities. Med Res Arch. 2023;11(6):10.18103\/mra.v11i6.3994.","DOI":"10.18103\/mra.v11i6.3994"},{"issue":"2","key":"3028_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/JCI89587","volume":"127","author":"S Osuka","year":"2017","unstructured":"Osuka S, Van Meir EG. Overcoming therapeutic resistance in glioblastoma: the way forward. J Clin Invest. 2017;127(2):415\u201326.","journal-title":"J Clin Invest"},{"issue":"2","key":"3028_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","volume":"187","author":"R Mathur","year":"2024","unstructured":"Mathur R, Wang Q, Schupp PG, et al. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell. 2024;187(2):446\u201363. e416.","journal-title":"Cell"},{"key":"3028_CR41","doi-asserted-by":"publisher","first-page":"114204","DOI":"10.1016\/j.biopha.2022.114204","volume":"158","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Etemad S, Rezaei S, et al. Progress in targeting PTEN\/PI3K\/Akt axis in glioblastoma therapy: Revisiting molecular interactions. Biomed Pharmacother. 2023;158:114204.","journal-title":"Biomed Pharmacother"},{"issue":"7897","key":"3028_CR42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41586-021-04393-3","volume":"602","author":"C Hu","year":"2022","unstructured":"Hu C, Leche CA 2nd, Kiyatkin A, et al. Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias. Nature. 2022;602(7897):518\u201322.","journal-title":"Nature"},{"issue":"6","key":"3028_CR43","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41556-024-01428-5","volume":"26","author":"L Wu","year":"2024","unstructured":"Wu L, Zhao Z, Shin YJ, et al. Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma. Nat Cell Biol. 2024;26(6):1003\u201318.","journal-title":"Nat Cell Biol"},{"issue":"2 Pt 1","key":"3028_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.gene.2015.08.060","volume":"575","author":"Z Duzgun","year":"2016","unstructured":"Duzgun Z, Eroglu Z, Biray Avci C. Role of mTOR in glioblastoma. Gene. 2016;575(2 Pt 1):187\u201390.","journal-title":"Gene"},{"issue":"1","key":"3028_CR45","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","volume":"11","author":"W Zhou","year":"2020","unstructured":"Zhou W, Yao Y, Scott AJ, et al. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nat Commun. 2020;11(1):3811.","journal-title":"Nat Commun"},{"issue":"13\u201315","key":"3028_CR46","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1089\/ars.2022.0088","volume":"39","author":"J Bailleul","year":"2023","unstructured":"Bailleul J, Vlashi E, Glioblastomas. Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance. Antioxid Redox Signal. 2023;39(13\u201315):957\u201379.","journal-title":"Antioxid Redox Signal"},{"key":"3028_CR47","doi-asserted-by":"crossref","unstructured":"Zhou W, Wahl DR. Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance. Cancers (Basel). 2019;11(9):1231.","DOI":"10.3390\/cancers11091231"},{"issue":"11","key":"3028_CR48","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/neuonc\/noad103","volume":"25","author":"J Bailleul","year":"2023","unstructured":"Bailleul J, Ruan Y, Abdulrahman L, et al. M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance. Neuro Oncol. 2023;25(11):1989\u20132000.","journal-title":"Neuro Oncol"},{"key":"3028_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2024.08.001","volume":"106\u2013107","author":"C Jiang","year":"2024","unstructured":"Jiang C, Tan X, Liu N, Yan P, Hou T, Wei W. Nutrient sensing of mTORC1 signaling in cancer and aging. Semin Cancer Biol. 2024;106\u2013107:1\u201312.","journal-title":"Semin Cancer Biol"},{"key":"3028_CR50","doi-asserted-by":"crossref","unstructured":"Harachi M, Masui K, Okamura Y, Tsukui R, Mischel PS, Shibata N. mTOR Complexes as a Nutrient Sensor for Driving Cancer Progression. Int J Mol Sci. 2018;19(10):3267.","DOI":"10.3390\/ijms19103267"},{"issue":"6","key":"3028_CR51","first-page":"1206","volume":"21","author":"J Liu","year":"2017","unstructured":"Liu J, Li T, Liu XL. DDA1 is induced by NR2F6 in ovarian cancer and predicts poor survival outcome. Eur Rev Med Pharmacol Sci. 2017;21(6):1206\u201313.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8016","key":"3028_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493\u2013500.","journal-title":"Nature"},{"key":"3028_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fonc.2012.00029","volume":"2","author":"JM Li","year":"2012","unstructured":"Li JM, Jin J. CRL Ubiquitin Ligases and DNA Damage Response. Front Oncol. 2012;2:29.","journal-title":"Front Oncol"},{"key":"3028_CR54","doi-asserted-by":"publisher","first-page":"1326633","DOI":"10.3389\/fmolb.2023.1326633","volume":"10","author":"CT Supuran","year":"2023","unstructured":"Supuran CT. Carbonic anhydrase versatility: from pH regulation to CO(2) sensing and metabolism. Front Mol Biosci. 2023;10:1326633.","journal-title":"Front Mol Biosci"},{"key":"3028_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","volume":"623","author":"A Waheed","year":"2017","unstructured":"Waheed A, Sly WS. Carbonic anhydrase XII functions in health and disease. Gene. 2017;623:33\u201340.","journal-title":"Gene"},{"key":"3028_CR56","doi-asserted-by":"publisher","first-page":"13103","DOI":"10.1038\/ncomms13103","volume":"7","author":"J Ratajczak","year":"2016","unstructured":"Ratajczak J, Joffraud M, Trammell SA, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat Commun. 2016;7:13103.","journal-title":"Nat Commun"},{"issue":"29","key":"3028_CR57","doi-asserted-by":"publisher","first-page":"eadi4862","DOI":"10.1126\/sciadv.adi4862","volume":"9","author":"MV Damgaard","year":"2023","unstructured":"Damgaard MV, Treebak JT. What is really known about the effects of nicotinamide riboside supplementation in humans. Sci Adv. 2023;9(29):eadi4862.","journal-title":"Sci Adv"},{"issue":"10","key":"3028_CR58","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s42255-023-00883-y","volume":"5","author":"C Wang","year":"2023","unstructured":"Wang C, Huang M, Lin Y, et al. ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy. Nat Metab. 2023;5(10):1765\u201386.","journal-title":"Nat Metab"},{"key":"3028_CR59","doi-asserted-by":"crossref","unstructured":"Ma W, Zhou S. Metabolic Rewiring in the Face of Genomic Assault: Integrating DNA Damage Response and Cellular Metabolism. Biomolecules. 2025;15(2):168.","DOI":"10.3390\/biom15020168"},{"key":"3028_CR60","doi-asserted-by":"crossref","unstructured":"Ghanem MS, Monacelli F, Nencioni A. Advances in NAD-Lowering Agents for Cancer Treatment. Nutrients. 2021;13(5):1665.","DOI":"10.3390\/nu13051665"},{"key":"3028_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcell.2016.00027","volume":"4","author":"PC McDonald","year":"2016","unstructured":"McDonald PC, Chafe SC, Dedhar S. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction. Front Cell Dev Biol. 2016;4:27.","journal-title":"Front Cell Dev Biol"},{"key":"3028_CR62","doi-asserted-by":"crossref","unstructured":"Miranda-Galvis M, Teng Y. Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis. Int J Mol Sci. 2020;21(15):5487.","DOI":"10.3390\/ijms21155487"},{"issue":"7","key":"3028_CR63","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/1541-7786.MCR-09-0030","volume":"7","author":"G Frosina","year":"2009","unstructured":"Frosina G. DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Mol Cancer Res. 2009;7(7):989\u201399.","journal-title":"Mol Cancer Res"},{"key":"3028_CR64","doi-asserted-by":"publisher","first-page":"1535073","DOI":"10.3389\/fcell.2025.1535073","volume":"13","author":"S D\u2019Aprile","year":"2025","unstructured":"D\u2019Aprile S, Denaro S, Gervasi A, Vicario N, Parenti R. Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance. Front Cell Dev Biol. 2025;13:1535073.","journal-title":"Front Cell Dev Biol"},{"key":"3028_CR65","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1476-4598-13-144","volume":"13","author":"S Smalley","year":"2014","unstructured":"Smalley S, Chalmers AJ, Morley SJ. mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells. Mol Cancer. 2014;13:144.","journal-title":"Mol Cancer"},{"key":"3028_CR66","doi-asserted-by":"publisher","first-page":"9230479","DOI":"10.1155\/2018\/9230479","volume":"2018","author":"C Mecca","year":"2018","unstructured":"Mecca C, Giambanco I, Donato R, Arcuri C. Targeting mTOR in Glioblastoma: Rationale and Preclinical\/Clinical Evidence. Dis Markers. 2018;2018:9230479.","journal-title":"Dis Markers"},{"issue":"6","key":"3028_CR67","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017;168(6):960\u201376.","journal-title":"Cell"},{"issue":"1","key":"3028_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","volume":"21","author":"J Kim","year":"2019","unstructured":"Kim J, Guan KL. mTOR as a central hub of nutrient signalling and cell growth. Nat Cell Biol. 2019;21(1):63\u201371.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"3028_CR69","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1158\/0008-5472.CAN-12-4282","volume":"73","author":"C Shen","year":"2013","unstructured":"Shen C, Oswald D, Phelps D, et al. Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks. Cancer Res. 2013;73(11):3393\u2013401.","journal-title":"Cancer Res"},{"issue":"7880","key":"3028_CR70","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41586-021-03906-4","volume":"598","author":"G Kokic","year":"2021","unstructured":"Kokic G, Wagner FR, Chernev A, Urlaub H, Cramer P. Structural basis of human transcription-DNA repair coupling. Nature. 2021;598(7880):368\u201372.","journal-title":"Nature"},{"issue":"11","key":"3028_CR71","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ncb3629","volume":"19","author":"MA Reid","year":"2017","unstructured":"Reid MA, Dai Z, Locasale JW. The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat Cell Biol. 2017;19(11):1298\u2013306.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3028_CR72","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","volume":"6","author":"LE Navas","year":"2021","unstructured":"Navas LE, Carnero A. NAD(+) metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther. 2021;6(1):2.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"3028_CR73","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1074\/jbc.M116.761551","volume":"292","author":"S Gao","year":"2017","unstructured":"Gao S, Geng C, Song T, et al. Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase. J Biol Chem. 2017;292(9):3683\u201391.","journal-title":"J Biol Chem"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03028-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03028-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03028-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:03:13Z","timestamp":1788919393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03028-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03028-2","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal studies were approved by the Institutional Animal Care Use & Welfare Committee of the Center for Experimental Animal Research (ACUC-A01-2022-059, ACUC-A02-2025-005).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We, the authors, hereby declare that this manuscript is original, has not been published elsewhere, and is not under consideration by any other journal. Upon acceptance, we agree to grant the Publisher the right to publish, reproduce, and distribute this work in all forms and media.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"478"}}